Trump 'Solves' IVF Cost by Threatening Tariffs He Created
Bloomberg's latest dispatch hails Donald Trump's 'deal' with Germany's Merck KGaA to lower IVF drug prices, framed as a win for American families. The catch? The price reduction is in exchange for relief from tariffs that Trump's own administration either imposed or threatened. It’s the political equivalent of setting your own house on fire, then taking credit for extinguishing a small blaze with
your garden hose. This 'solution' conveniently ignores the broader issue of pharmaceutical price gouging (a systemic issue he largely ignored) while showcasing Trump's preferred strong-arming tactics over actual policy reform. The media's framing here, focusing on the 'deal' without foregrounding the tariff context, is classic narrative control. It presents Trump as a problem-solver, not a
problem-initiator, in a theatrical display engineered for a public often starved for good news, however manufactured. One might wonder, how many times must we watch this particular play?